Marimed (OTCMKTS:MRMD) Releases Earnings Results

Marimed (OTCMKTS:MRMD) posted its quarterly earnings results on Monday. The company reported $0.02 EPS for the quarter, Bloomberg Earnings reports. The business had revenue of $25.67 million for the quarter.

Shares of Marimed stock traded down $0.04 during trading on Tuesday, reaching $1.63. 147,123 shares of the company’s stock were exchanged, compared to its average volume of 340,069. Marimed has a 1-year low of $1.21 and a 1-year high of $5.80. The company has a 50-day simple moving average of $1.74.

About Marimed



MariMed Inc provides consulting services for the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. The company also develops and manages facilities for the cultivation, production, and dispensing of legal cannabis and cannabis-infused products under the Kalm Fusion brand name.

Featured Article: How is a management fee different from a performance fee?

Earnings History for Marimed (OTCMKTS:MRMD)

Receive News & Ratings for Marimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marimed and related companies with MarketBeat.com's FREE daily email newsletter.